S I Abrams - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

S I Abrams

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

Expert Opinion on Investigational Drugs|July 5, 2005

Cancer vaccine developmentJ Schlom, K Y Tsang, J A Kantor, et al.

Cellular Immunology|March 26, 1998

Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutationsS I Abrams, S N Khleif, E S Bergmann-Leitner, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999

A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumorsS N Khleif, S I Abrams, J M Hamilton, et al.

European Journal of Immunology|September 1, 1995

Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21S I Abrams, M J Dobrzanski, D T Wells, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

Expert Opinion on Investigational Drugs|July 5, 2005

Cancer vaccine developmentJ Schlom, K Y Tsang, J A Kantor, et al.

Cellular Immunology|March 26, 1998

Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutationsS I Abrams, S N Khleif, E S Bergmann-Leitner, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999

A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumorsS N Khleif, S I Abrams, J M Hamilton, et al.

European Journal of Immunology|September 1, 1995

Peptide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21S I Abrams, M J Dobrzanski, D T Wells, et al.

Pageof 4